Fibrocystic mastopathy

Authors

  • І. І. Смоланка Oncology Institute of the NAMS of Ukraine, Ukraine
  • А. О. Ляшенко Oncology Institute of the NAMS of Ukraine, Ukraine
  • А. О. Ляшенко Oncology Institute of the NAMS of Ukraine, Ukraine
  • А. О. Ляшенко Oncology Institute of the NAMS of Ukraine, Ukraine

DOI:

https://doi.org/10.18370/2309-4117.2014.18.17-23

Keywords:

breasts, breast, fibrocystic breast disease, Mastodynon

Abstract

Fibrocystic breast disease is the most common of breast diseases in the obstetrician-gynecologist practice, which is characterized by impaired epithelial and connective relations components, a wide range of proliferative and regressive changes in breast tissue.
Important role in the etiology and pathogenesis of fibrocystic breast disease belong to relative or absolute hyperestrogenemia and progesterone deficiency condition, i.e., a violation of the relation between estrogen and progesterone.
There is diffuse and nodular form of the fibrocystic breast disease. Diagnosis of mastitis is based on inspection, palpation, mammography, ultrasound, nodules puncture, suspicious areas and cytological examination of punctate. Non-hormonal drugs (including phyto-drug Mastodynon) and hormonal medications (antiestrogens, prolactin secretion inhibitors, gonadotropin-releasing hormone agonists, progestin, and combined hormonal contraceptives) are used for treatment. 

Author Biographies

І. І. Смоланка, Oncology Institute of the NAMS of Ukraine

MD, Professor, Head of the Breast Pathology Department

А. О. Ляшенко, Oncology Institute of the NAMS of Ukraine

PhD, Breast Pathology Department

А. О. Ляшенко, Oncology Institute of the NAMS of Ukraine

PhD, Breast Pathology Department

А. О. Ляшенко, Oncology Institute of the NAMS of Ukraine

PhD, Breast Pathology Department

References

  1. Apanasevich V.I. «Sketches about Clinical Oncology. Breast Fibroadenomatosis.» Modern Oncology (2001):45-51.
  2. Andreeva E.N., Ledneva E.V. «Key aspects of the etiology and pathogenesis of fibrocystic disease of the breast.» Obstetrics and Gynecology, 6(2002):7-9.
  3. Akhurian E.R., Burdina L.M., Volobuev A.I. «Obstetrics and Gynecology.», 12(1990):3-6.
  4. Baltinja D., Srebniy A. «Conservative treatment of fibrocystic disease (masthopatia).» www.mastopatia.ru/artc2.html.
  5. Bohman Y.V., Tkeshelashvili V.T., Vishnevsky A.S., Volkova A.T. «Obstetrics and Gynecology.» 7(1987):12-13.
  6. Burdina L.M. «Clinical and radiological features of breast disease in gynecological patients of reproductive age with neuroendocrine pathology.» Author. thesis for PhD,M. (1993):54 p.
  7. Dedov I.I. Dedov V.I. «Biorhythms of hormones.» M. (1992):126 p.
  8. Kirillov V.S. «Pathogenetic approach to the treatment of the various forms of mastitis.» Attending Physician, 1(2005).
  9. Kulakov V.I. «Gynecological endocrinology: new aspects of the old problems.» Obstetrics and Gynecology, 2(2003):6-9.
  10. Manusharova R.A., Cherkezova E.I.«Fibrocystic breast disease: clinical features, diagnosis and treatment.» Attending Physician, 10(2004).
  11. Piddubny M.I. «The combination of uterine fibroids with dyshormonal breast pathology.» Author. thesis for PhD. M. (1994):23 p.
  12. Piddubny M.I., Zhuchenko O.G., Bagaeva T.V., Khaskhanova L.H. «The combination of gynecological diseases with pathological changes in the breasts.» Russian Gazette of Obstetrician and Gynecologist, 2(2002):47-49.
  13. Prilepskaya V.N., Shvetsova O.B. «Benign breast diseases: principles of therapy.» Gynecology, 2(6) (2002).
  14. Rozhkova N.I. «X-ray diagnosis of breast diseases.» M. (1993).
  15. Sidorova I.S., Piddubny M.I., Levakov S.A. et al. «Bulletin of the Russian Association of Obstetricians and Gynecologists.» 1(1999):92-95.
  16. Smetnik V.P., Tumilovich L.G. «Non-operative gynecology.» M. (1997):543 p
  17. Tagiyeva T.T. «Fibrocystic breast disease.» Gynecology, 7(3) (2005).
  18. Tagiyeva T.T., Volobuev A.I. «Mastodynon use in women with fibrocystic breast disease.» Health Protection of Ukraine, 5(2002).
  19. Khaskhanova L.H., Piddubny M.I., Guriev T.D. «Obstetrics and Gynecology.» 1(1998):57-61.
  20. Tsvelev Y.V., Ilyin A.B. «Journal of Obstetrics and Women’s Diseases.» 1(1999):63-71.
  21. Chistyakov S.S., Grebennikova O.P., Shikina V.E. «Comprehensive treatment of fibrocystic disease.»// http // www.mastopatia.ru /pronk.html. 2003.
  22. Chistyakov S.S., Gabunia Z.R., Grebennikova O.P. «Oncological aspects of breast diseases.» Gynecology, 3(5) (2001):102-104
  23. Marchbanks P.A., McDonald J.A. et al. New Engl. J Med, 346(2002):2025-2032.

Downloads

Published

2014-11-17

How to Cite

Смоланка, І. І., Ляшенко, А. О., Ляшенко, А. О., & Ляшенко, А. О. (2014). Fibrocystic mastopathy. REPRODUCTIVE ENDOCRINOLOGY, (18), 17–23. https://doi.org/10.18370/2309-4117.2014.18.17-23

Issue

No. 18 (2014)

Section

Tumors and pretumoral pathology

License

Copyright (c) 2014 І. І. Смоланка, А. О. Ляшенко, А. О. Ляшенко, А. О. Ляшенко

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.